Development of tubulin polymerization inhibitors as anticancer agents-Reference-Cited by-同舟云学术

Development of tubulin polymerization inhibitors as anticancer agents

Published:2023-11-02 Issue:11 Volume:33 Page:797-820
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Peerzada Mudasir Nabi¹²,Dar Mohammad Sultan³,Verma Saurabh¹

Affiliation:

1. Tumor Biology Department, Drug Discovery Laboratory, National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India

2. Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India

3. Department of Neurosurgery, Sub-District Hospital Sopore, Jammu and Kashmir, India

Funder

Indian Council of Medical Research

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2023.2291390

Reference106 articles.

1. The tubulin code and its role in controlling microtubule properties and functions

2. Novel Agents That Target Tublin and Related Elements

3. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development

4. Microtubules: Evolving roles and critical cellular interactions

5. Microtubule-binding agents: a dynamic field of cancer therapeutics

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC;European Journal of Medicinal Chemistry;2024-09

2. Zerumbone Induces Apoptosis and Inhibits Migration of A2058 Melanoma stem-like Cells by Producing Reactive Oxygen Species, Causing G2/M Cell Cycle Arrest, and Controlling the Expression of Genes Linked to Metastasis;Indian Journal of Clinical Biochemistry;2024-08-16

3. Cyclopenta[b]indoles as novel antimicrotubule agents with antileukemia activity;Toxicology in Vitro;2024-08

4. Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-08

5. Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies;MedComm;2024-07-28